Showing 1 - 19 results of 19 for search 'S. Faderl', query time: 0.04s
Refine Results
-
1
Influence of Add-On Perforated Plates on the Protective Performance of Light-Weight Armour Systems by Teresa FRAS, Norbert FADERL
Published 2018-03-01
Article -
2
-
3
High-Velocity Impacts of Pyrophoric Alloy Fragments on Thin Armour Steel Plates by Evaristo Santamaria Ferraro, Marina Seidl, Tom De Vuyst, Norbert Faderl
Published 2021-08-01
Article -
4
Optimizing Viscoelastic Properties of Rubber Compounds for Ballistic Applications by Janis Karl, Franziska Kirsch, Norbert Faderl, Leonhard Perko, Teresa Fras
Published 2020-11-01
Article -
5
Development of a new method to determine dynamic tensile strength of ballistic yarns by Nuesing R., Faderl N., Nussbaum J., Ha-Minh C., Boussu F.
Published 2012-08-01
Article -
6
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysi... by Jorge E. Cortes, Tara L. Lin, Kobby Asubonteng, Stefan Faderl, Jeffrey E. Lancet, Thomas Prebet
Published 2022-10-01
Article -
7
-
8
Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML by Jorge E. Cortes, Tara L. Lin, Geoffrey L. Uy, Robert J. Ryan, Stefan Faderl, Jeffrey E. Lancet
Published 2021-07-01
Article -
9
-
10
Multiscale Investigation of Microcracks and Grain Boundary Wetting in Press-Hardened Galvanized 20MnB8 Steel by Martin Arndt, Philipp Kürnsteiner, Tia Truglas, Jiri Duchoslav, Kurt Hingerl, David Stifter, Christian Commenda, Johannes Haslmayr, Siegfried Kolnberger, Josef Faderl, Heiko Groiss
Published 2023-12-01
Article -
11
P516: CARDIOTOXICITY OF CPX-351 VS 7 + 3 IN PATIENTS WITH UNTREATED HIGH-RISK ACUTE MYELOID LEUKEMIA by Joshua D. Mitchell, Michael Pfeiffer, John Boehmer, John Gorcsan, Nalina Dronamraju, Stefan Faderl, Tara L. Lin, Geoffrey L. Uy, Jeffrey Lancet, Jorge Cortes
Published 2023-08-01
Article -
12
FIVE-YEAR FINAL RESULTS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA (AML) by J.E. Lancet, T.L. Lin, D. Hogge, S.R. Solomon, G.J. Schiller, M.J. Wieduwilt, R. Martin, S. Faderl, Y. Chang, J.E. Cortes
Published 2020-11-01
Article -
13
P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA by J. McCloskey, V. Pullarkat, G. Mannis, T. L. Lin, S. A. Strickland, A. T. Fathi, H. P. Erba, S. Faderl, D. Chakravarthy, Y. Lutska, V. Chandrasekaran, R. S. Cheung, M. Levis
Published 2022-06-01
Article -
14
P515: LOWER-INTENSITY CPX-351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY by G. L. Uy, V. A. Pullarkat, P. Baratam, R. K. Stuart, R. B. Walter, E. S. Winer, S. Faderl, V. Chandrasekaran, Q. Wang, D. Chakravarthy, R. S. Cheung, T. L. Lin
Published 2022-06-01
Article -
15
Hydrogen Insertion into Complex-Phase High-Strength Steel during Atmospheric Corrosion at Low Relative Humidity by Gabriela Schimo-Aichhorn, Ines Traxler, Andreas Muhr, Christian Commenda, Darya Rudomilova, Oldřich Schneeweiss, Gerald Luckeneder, Hubert Duchaczek, Karl-Heinz Stellnberger, Josef Faderl, Tomáš Prošek, David Stifter, Achim Walter Hassel, Sabine Hild
Published 2022-04-01
Article -
16
CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial by Scott R. Solomon, Bayard L. Powell, Jamie Koprivnikar, Catherine Lai, Heather Male, Laura C. Michaelis, Laura F. Newell, David Sanford, Jack Jenkins, Amy Zelaya, Sheryl Coppola, Stefan Faderl, Roland B. Walter
Published 2024-02-01
Article -
17
Descriptive analyses of maternally-derived antibody levels against porcine circovirus 2 (PCV-2) in 3- and 21-day-old piglets from farms of four European countries using different v... by M. Sibila, A. Llorens, E. Huerta, C. Fablet, M. Faderl, L. Ferrari, N. Rose, A. Palzer, P. Martelli, M. C. Venegas-Vargas, D. Fredrickson, L. Taylor, M. Balasch, M. Bandrick, J. Segalés
Published 2022-10-01
Article -
18
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra<sup>®</sup>, TLK199), a novel glutathione analog prodrug in patients with... by Burris Howard, Williams Stephanie, Emanuel Peter, Piro Lawrence, Ochoa Leonel, Callander Natalie, Galili Naomi, Raza Azra, Faderl Stefan, Estrov Zeev, Curtin Peter, Larson Richard A, Keck James G, Jones Marsha, Meng Lisa, Brown Gail L
Published 2009-05-01
Article -
19
The ESRP1-GPR137 axis contributes to intestinal pathogenesis by Lukas Franz Mager, Viktor Hendrik Koelzer, Regula Stuber, Lester Thoo, Irene Keller, Ivonne Koeck, Maya Langenegger, Cedric Simillion, Simona P Pfister, Martin Faderl, Vera Genitsch, Irina Tcymbarevich, Pascal Juillerat, Xiaohong Li, Yu Xia, Eva Karamitopoulou, Ruth Lyck, Inti Zlobec, Siegfried Hapfelmeier, Rémy Bruggmann, Kathy D McCoy, Andrew J Macpherson, Christoph Müller, Bruce Beutler, Philippe Krebs
Published 2017-10-01
Article